To the Editor: The article by Philip Sambrook et al on the impact of adverse news media on prescriptions for osteoporosis1 contains a number of serious errors and ignores more recent data.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Alastair Goss has been a consultant to Merck and Novartis on ONJ, and has provided expert testimony for the plaintiffs in the US class action against Merck with respect to alendronate.